Key Personnel – Lee's Pharmaceutical

About Us

Directors and
Key Personnel

Key Personnel

Chow Yiu Ming 
Group Chief Financial Officer & Company Secretary
Mr. Chow Yiu Ming joined the Company in October 2014 and is responsible for the accounting and corporate finance functions of the Group. He has over 22 years of experience in accounting, auditing and finance. Prior to joining the Group, he had held various senior positions with listed and private companies in Hong Kong. He is a fellow member of the Association of Chartered Certified Accountants and a member of the Hong Kong Institute of Certified Public Accountants. He holds a Bachelor of Business Administration degree, majoring in Accounting and Finance, from the University of Hong Kong and a Master of Science in Professional Accountancy degree from the University of London.

Jiao Zhongyu 
Chief Officer of Enterprise Development Department of the Group
Mr. Jiao Zhongyu is responsible for the government affair and legal affairs of the Group in the PRC. He was appointed as the legal adviser of PRC investment by the Group in 1999 in his capacity as a practising lawyer in PRC. He has been appointed as the director of Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke Hefei”) since 2010 and has extensive experience in the government affair and legal affairs. In 2012, the Group established the Enterprise Development Department and he has been appointed as the Chief Officer thereof and responsible for the Group’s strategic planning and development.

Lau Lit-Fui
Chief Operating Officer of China Ophthalmology Focus Limited and President of Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited, PhD
Dr. Lau Lit-Fui holds the PhD from the University of Connecticut Health Center. Before joining the Group, he had served as the associate director for the American GlaxoSmithKline R&D China, and has been responsible for the research and development of new drugs for over 23 years. He has extensive experience in management of the research and development of new drugs. He joined the Group in 2012 as the General Manager of Shanghai branch of Zhaoke Hefei and was responsible for the business development of Eastern China region. He had also served as the Head of Research and Development of the Group and was responsible for the management of the research and development of drugs. During the period from May 2016 to March 2019, he was appointed as the President and General Manager of CVie Therapeutics Limited, the then associated company of the Group in Taiwan. He was currently been appointed as Chief Operating Officer of China Ophthalmology Focus Limited and President of Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited and is responsible for the management of the research and development of ophthalmic products.

Victor Tsui
Chief Manufacturing Officer, Licensed Professional Engineer, P.E. MSc
Mr. Victor Tsui graduated from The Hong Kong Polytechnics University and University of Wisconsin with a master degree in Engineering. Before joining the Group, he worked for various pharmaceuticals companies in the United States for over 25 years and was responsible for production management. He joined the Group in 2009 as Chief Operating Officer of Powder Pharmaceuticals Incorporated (“PPI”, an associated company of the Group). He has been appointed as Chief Manufacturing Officer of the Group since 2012 to oversee the Group’s manufacturing operations. He has also been appointed as director of PPI since 22 March 2013.

Yang Zhongqiang 
Executive Deputy General Manager of Zhaoke Pharmaceutical (Hefei) Company Limited
Mr. Yang Zhongqiang holds a master’s degree in Pharmaceutical Engineering of Shandong University and has a practicing pharmacist certification. He has been working for the Group for more than 20 years, and has been working in the Department of Research and Development of New Drugs and Quality Department of Zhaoke Hefei. He has extensive experience in the research and development of new drug, project management and quality management. He had served as the quality authorised person of Zhaoke Hefei since 2012 to oversee the company’s drug quality management and protection works. In 2017, he has been appointed as the Executive Deputy General Manager of Zhaoke Hefei.

Dai Xiangrong
Group Deputy General Manager and President & Chief Operating Officer of China Oncology Focus Limited
Mr. Dai Xiangrong holds a bachelor’s degree of biochemistry and molecular biology, and a master’s degree of biochemistry of Anhui Agricultural University. He is also a licensed pharmacist. He joined the Group in 2007 and is responsible for the research and development of new drugs. He has extensive experience in preclinical studies, clinical research and registration of new drugs. He was responsible for various new drug development programs and succeeded in bringing the programs to clinical research studies. He has been appointed as Senior Director of Research and Development Centre of the Group in 2017 and has been appointed as Group Deputy General Manager since March 2019. He has also been appointed as President and Chief Operating Officer of China Oncology Focus Limited in March 2018 and is fully responsible to the new drug development and registration.

Zhang Guohui
Deputy General Manager of Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited, MBA, BSc
Mr. Zhang Guohui has been working in Zhaoke Hefei for more than 20 years. He was responsible for the research and development of new drugs, production control and GMP management. He has extensive experience in the research and development and registration of new drugs and technology project management. The Research and Development Centre of the Group was established in 2012, and he had served as the director thereof and was responsible for new drug pre-clinical studies and clinical research, the additional development of launched products, drug registration affairs, science and technology project reporting and monitoring work of adverse drug reactions. In 2017, he has been appointed as the Deputy General Manager of Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited and is responsible for the research and development of ophthalmic products.

Li Lok-Yee Mandy
Associate Director, R&D of the Group, PhD
Dr. Mandy Li graduated with a Bachelor of Science degree in Biochemistry in 2000 from the Chinese University of Hong Kong where she also received her PhD in 2004. Before joining the Group, she had served as the Research Scientist for a local biopharmaceutical company focused on the research and development of innovative anticancer drugs. She joined the Group in 2014 and is responsible for the research and development of new drugs, project management, and business development and licensing. In 2019, she has been appointed as Associate Director, R&D of the Group and is mainly responsible for the project management and business development of the Group.

Zhang Zhenhua
Director of Human Resources and Development of the Group
Ms. Zhang Zhenhua holds a master’s degree of business administration of the Southern Cross University Australia. She has more than 25 years of working experience in multinational corporations and with broad knowledge and experience in human resources management. In September 2017, she has been appointed as the Director of Human Resources and Development of the Group and is responsible for the management of human resources and development of the Group.

Chen Yueshen
Director of Administration in China
Mr. Chen Yueshen had been serving for the Group for more than 20 years in various positions such as the Director and Deputy General Manager of Zhaoke Hefei, Chief Operating Officer of the Group and the Deputy General Manager of Zhaoke Pharmaceutical (Guangzhou) Limited. He was responsible for the daily operations of Zhaoke Hefei, including being responsible for the production and quality management of Zhaoke Hefei. He has extensive experience in quality management systems and GMP production. In November 2018, he has been appointed as the Director of Administration in China and is responsible for the Group’s administrative matters in China.

Yin Lei
Associate Director, R&D of the Group and Deputy General Manager of Zhaoke (Guangzhou) Pharmaceutical Limited
Mr. Yin Lei holds a bachelor’s degree from the Anhui University of Chinese Medicine. He is also a licensed pharmacist. He joined the Group in 2014 and is responsible for the research and development of new drugs. He has been engaged in drug research and development for nearly 20 years and has led to many successful cases in the field of small molecule drugs, peptide drugs and biochemical drugs. In 2019, he has been appointed as Associate Director, R&D of the Group and is fully responsible for the research and development of new drugs of the Group.

Xia Hongling
Deputy General Manager of Zhaoke Pharmaceutical (Hefei) Company Limited
Ms. Xia Hongling holds a Bachelor’s degree in Business Administration from the Renmin University of China and has the qualification of accountant in China. Before joining the Group, she had been responsible for the accounting and finance function with a large state-owned manufacturing enterprise for over 10 years. She joined the Group in 1997 and held various positions in accounting and logistics department in Zhaoke Hefei for over 20 years. She has extensive experience in accounting, finance and logistics management in pharmaceutical industry. She has been appointed as Deputy General Manager of Zhaoke Hefei since 2017.